Ticker Details
Tenaya Therapeutics, Inc.
IPO Date:	June 30, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$167.63M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.26 | 4.73%
Avg Daily Range (30 D):	$0.03 | 3.81%
Avg Daily Range (90 D):	$0.03 | 4.43%

Institutional Daily Volume
Avg Daily Volume:	1.45M
Avg Daily Volume (30 D):	4.33M
Avg Daily Volume (90 D):	4.33M

Trade Size
Avg Trade Size (Sh.):	314
Avg Trade Size (Sh.) (30 D):	484
Avg Trade Size (Sh.) (90 D):	463

Institutional Trades
Total Institutional Trades:	112
Avg Institutional Trade:	$1.62M
Avg Institutional Trade (30 D):	$.64M
Avg Institutional Trade (90 D):	$1.09M
Avg Institutional Trade Volume:	.47M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.96M
Avg Closing Trade (30 D):	$.77M
Avg Closing Trade (90 D):	$.77M
Avg Closing Volume:	706.21K

News

Mar 5, 2026 @ 6:35 PM Tenaya Therapeutics Stock Jumps After New Alnylam ... Source: Vandana Singh

Nov 8, 2025 @ 4:25 PM Tenaya Therapeutics Presents Promising Interim Cli... Source: Tenaya Therapeutics

Aug 31, 2025 @ 2:15 PM Tenaya Therapeutics Presents Interim Data from MyC... Source: Tenaya Therapeutics

Mar 4, 2025 @ 3:55 PM 2025 Market Prospects of Adeno-Associated Virus Ve... Source: Researchandmarkets.Com

Jun 27, 2024 @ 9:00 PM Tenaya Therapeutics Announces Research Leadership ... Source: Tenaya Therapeutics, Inc.

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.46	$-.09	$-.11
Diluted EPS	$-.46	$-.09	$-.11
Revenue	$.23M	$.23M	$M
Gross Profit
Net Income / Loss	$-83.01M	$-19.27M	$-20.18M
Operating Income / Loss	$-85.86M	$-20.07M	$-20.78M
Cost of Revenue
Net Cash Flow	$27.12M	$-19.66M	$44.24M
PE Ratio